ArticleFrontiers in aging neuroscience2019

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease.

Mar Cuadrado-Tejedor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.